CO-AX Accelerator at Sahlgrenska Science Park
CO-AX Accelerator is a non-profit healthtech accelerator in Gothenburg, Sweden, operated by Sahlgrenska Science Park AB. It supports healthtech, medtech, biotech, and deep tech startups through tiered programs without taking equity, having accelerated 155 startups since 2015.
- Company typePrivate
- Founded2017
- HeadquartersGothenburg, Sweden
- Headcount1–10
- GTM typeB2B
- OfferingServices
What CO-AX Accelerator at Sahlgrenska Science Park does
CO-AX Accelerator is a non-profit healthtech accelerator operated by Sahlgrenska Science Park AB, based at Sahlgrenska Science Park in Gothenburg, Sweden. Founded in 2015 and supported by a team of 8, the accelerator provides tiered programs—Open Coaching, Prepare (pre-incubation), Incubate, Accelerate, and a Product-Market Fit Assessment in partnership with UC Berkeley Deep Tech Innovation Lab—targeting healthtech, medtech, biotech, and deep tech startups. CO-AX offers 11 service lines spanning capital and investor readiness, regulatory compliance, IP and legal, funding and grants, technology and interoperability, test and validation, market access, sustainability, internationalization, and marketing and communication. The organization has supported 155 startups cumulatively, with portfolio companies collectively raising 8.03 BSEK and achieving 9.8 BSEK in combined market value, creating 653 jobs.
The accelerator operates on a no-equity model, charging startups a modest monthly fee of 1,000 SEK (VAT excluded) billed quarterly. Revenue is supplemented through soft funding facilitation (Vinnova, ALMI, Västra Götalandsregionen, and EU grants). Distribution is community-led and event-driven: CO-AX recruits through periodic application windows for Spring and Fall cohorts and participates in Nordic healthtech events including Vitalis, TechBBQ, Nordic Life Science Days, and Slush. Strategic partnerships extend the accelerator's reach—HealthTech Nordic Community provides access to 260+ peer startups, Nordic Proof enables structured validation across Nordic healthcare systems, and Mediq Innovation Experts and Swecare support German market entry.
The current portfolio breakdown is 60% healthtech, 30% medtech, and 10% biotech, with the Spring 2026 cohort including AI-driven companies Silico, AI4ra, K-stem alongside Realign and Lifelink. Notable alumni outcomes include Captario exceeding 30 MSEK revenue in 2023, Detectivio achieving ISO 13485 certification, Ventrilabs holding 6 patents, and Mirno winning the HealthTech Award 2026. CO-AX is governed under Swedish private limited company structure (Sahlgrenska Science Park AB, org. nr 556547-7832) and has recently expanded into European-level policy engagement through the PRECISEU Consortium.
CO-AX Accelerator at Sahlgrenska Science Park firmographics
Firmographics- Name
- CO-AX Accelerator at Sahlgrenska Science Park
- Legal name
- Sahlgrenska Science Park AB
- Website
- https://coax.health
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CO-AX Accelerator is a non-profit healthtech accelerator in Gothenburg, Sweden, operated by Sahlgrenska Science Park AB. It supports healthtech, medtech, biotech, and deep tech startups through tiered programs without taking equity, having accelerated 155 startups since 2015.
- Ownership category
- akta.pro rank
CO-AX Accelerator at Sahlgrenska Science Park industry classification
Industry- Product category
- Healthtech Startup Acceleration Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- akta.pro primary industry
- Corporate Accelerators & Startup Programs (FSANAHAD)
Keywords
Where CO-AX Accelerator at Sahlgrenska Science Park is headquartered
LocationHeadquarters
- HQ city
- Gothenburg
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
CO-AX Accelerator at Sahlgrenska Science Park business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Program Membership Fees: CO-AX charges a monthly fee of 1000 SEK (VAT) for participation in their programs, billed on a quarterly basis. This fee partially covers use of facilities and internal events, and requires a small monetary skin in the game from startups. The accelerator explicitly states they do not invest or take equity in portfolio companies.
- Soft Funding Facilitation: CO-AX facilitates access to soft funding opportunities through national and EU grants, connecting startups with Vinnova, ALMI, and Västra Götalandsregionen funding programs. They also provide verification funding support and connect companies with grant opportunities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | CO-AX Accelerator Program - Monthly membership for startup support |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
CO-AX Accelerator at Sahlgrenska Science Park product offering
Product offeringCore offering
CO-AX Accelerator is a healthtech-focused startup accelerator that runs tiered programs (Open Coaching, Prepare pre-incubation, Incubate, and Accelerate) and a partnership program with UC Berkeley for US Product-Market Fit assessment. It sells structured business advisory services covering capital and investments, strategy and industry insight, compliance and regulatory framework, IP and legal, funding and grants, technology and interoperability, test and validation, market access, sustainability, internationalisation, and marketing/communication. The accelerator charges a 1,000 SEK monthly fee (billed quarterly) and explicitly does not take equity in portfolio companies.
Product overview
CO-AX Accelerator at Sahlgrenska Science Park is a healthtech accelerator offering a tiered program structure (Open Coaching, Prepare pre-incubation, Incubate, Accelerate, and UC Berkeley partnership) alongside comprehensive support services. The programs provide tailored mentorship and business development support, while services span Capital & Investments, Strategy & Industry Insight, Compliance & Regulatory Framework, IP & Legal, Funding & Grants, Technology & Interoperability, Test & Validation, Market Access, Sustainability, Internationalisation, and Marketing & Communication. The accelerator does not take equity and charges a monthly fee of 1000 SEK for participation.
Differentiator
Problem solved
Functional benefit
Products and services
- CO-AX Open Coaching Free coaching session with CO-AX healthtech experts for aspiring entrepreneurs to explore their concept, understand the industry landscape, and accelerate their journey.
- CO-AX Prepare Pre-incubation program for aspiring healthtech entrepreneurs using the Sustainable Business Canvas Model and Innovation Readiness Levels to formulate a solid business strategy.
- Incubate Program Early-phase program providing personalized weekly support from business advisors, connecting startups with specialized consultants and partial financial support through verification funding.
- Accelerate Program Go-to-market acceleration program with strategic roadmaps, MVP validation, Product-Market Fit studies, investor access, and internationalization support.
- CO-AX Product-Market Fit Assessment Program USA Partnership with UC Berkeley Deep Tech Innovation Lab providing 250-350 hours of dedicated graduate student team support for market analysis and US market entry for Nordic deep tech startups.
- Capital and Investments Investor readiness support, strategic positioning, and networking with investors, experts, and future partners through curated matchmaking and exclusive events.
- Strategy and Industry Insight Strategic guidance including product-market fit assessment, business modelling, customer ROI and impact insights, and global scalability mapping.
- Compliance and Regulatory Framework Four-stage compliance journey (Orientate, Structure, Execute, Grow) covering EU MDR, EU IVDR, and Swedish Medical Products Agency guidance.
- IP and Legal IP strategy support including asset analysis, patent guidance, and connections to industry experts for protecting innovations.
- Funding and Grants Soft funding opportunities through national and EU grants, eligibility guidance, application strategy, and connections to partners for collaborative projects.
- Technology and Interoperability Strategic architecture decisions for cloud, AI tools, and data standards, helping startups build scalable and adaptable technical foundations.
- Test and Validation Opportunities Access to healthcare providers and testing environments including Nordic Proof network and Leap for Life for real-world validation across local, national, and international ecosystems.
- Market Access Market entry strategy covering reimbursement and pricing guidance, provider and payer adoption support, and tailored market trips.
- Sustainability Four-stage sustainability journey (Orientate, Structure, Execute, Grow) integrating environmental and social impact into business growth.
- Internationalisation and Scaling Global network and guidance for international expansion, connecting startups with industry partners, investors, and innovation hubs.
- Marketing and Communication Brand development, investor pitch materials, digital presence, and event visibility support for startup growth.
Quantifiable outcome
- 155 startups accelerated
- +5 more outcomes
Companies that use CO-AX Accelerator at Sahlgrenska Science Park
Customer profileNamed customers17 records
Segments3 records
Ideal customer profiles2 records
CO-AX Accelerator at Sahlgrenska Science Park technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CO-AX Accelerator at Sahlgrenska Science Park partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- PRECISEU ConsortiumcoreSahlgrenska Science Park is partner in PRECISEU consortium working with European Parliament on life sciences innovation policy. Project involves 150+ stakeholders across 10 European regions to identify barriers and opportunities for personalised medicine and advanced therapies, focusing on regulation, clinical validation, reimbursement, and market access.
- HealthTech Nordic CommunitycoreCO-AX is co-founder of HealthTech Nordic Community, a network of 260+ HealthTech, Medtech and Biotech startups and scaleups. The partnership supports members through events, an investor platform, Knowledge Boosters, and global networks of healthcare providers and market access partners.
- Nordic ProofcoreOne stop shop for test and validation in the Nordics. Nordic Proof provides structured access to a leading network of partners from renowned incubators, health institutions, and healthcare testing hubs and world-class health services. Helps innovators refine and prove their solutions at every stage.
- UC Berkeley Haas Deep Tech Innovation LabcoreUnique partnership offering Nordic health deep tech SMEs opportunity to conduct Product-Market Fit Assessment with UC Berkeley. Program provides 250-350 hours of graduate student team support to analyze competitive landscapes, assess market opportunities, and review IP and regulatory considerations for US market entry.
- Innovationsplattformen, VGRcorePartnership with Innovationsplattformen at Västra Götalandsregionen strengthens innovation capacity of the healthcare system. Supports high-quality and sustainable innovation collaborations, transformation of healthcare, and contributes to regional and national growth in life science sector.
- Leap for LifeminorHalland's platform for health innovation uniting public, private, and academic stakeholders. Provides high-quality test environments for meaningful validation and co-creation of healthcare solutions.
- Mediq Innovation ExpertscorePartnership with Mediq Innovation Experts (15 years experience, 55 implemented projects) supports Swedish MedTech companies approaching the German market. Provides expertise in navigating the large but complex German market through extensive network across academia, healthcare, and industry.
- SwecarecorePartnership with Swecare supports Swedish healthcare and life science companies in international markets. Collaborates with CO-AX on delegation trips to Germany connecting startups with clinical innovation lighthouses and industry partners.
- VinnovaminorSwedish Innovation Agency partnership for delegation trips supporting Swedish MedTech companies in accessing international markets. Vinnova provides funding and strategic support for innovation initiatives.
- Center for Disaster MedicineminorCenter for Disaster Medicine (national center of expertise under Swedish National Board of Health and Welfare) relocated to Medicinaregatan 8A innovation hub. Focuses on disaster medicine, healthcare during crises and war, total defence medicine. Strengthens collaborative ecosystem and connection between research, innovation, preparedness, and practical healthcare.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
CO-AX Accelerator at Sahlgrenska Science Park competitors and assessment
Company assessmentBroad incumbents
- JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of healthcare innovation incubators providing lab space, mentorship, and industry resources to biotech, medtech, and healthtech startups; comparable to CO-AX as a sector-specialized incubator but at substantially larger scale.
- EIT Health: Pan-European network (backed by EU) running accelerator and innovation programs for healthtech startups across multiple regions; comparable to CO-AX as a healthtech-focused startup support organization with a much larger geographic and funding footprint.
- Roche Pharma Day / pRED Innovation Hub: Roche's corporate innovation and partnership programs that engage healthtech and digital health startups for collaboration and acceleration; comparable to CO-AX as a pharma-corporate-sponsored healthtech support program.
Direct peers
- AstraZeneca BioVentureHub: AstraZeneca-operated biotech and healthtech incubator located in Gothenburg, Sweden, directly comparable to CO-AX by geography, sector focus, and mission to accelerate Nordic life-science startups through tailored company support.
- Karolinska Institutet Innovations (KI Innovations): Swedish innovation office affiliated with Karolinska Institutet that supports healthtech and life science startups from academic research; comparable to CO-AX as a Sweden-based healthtech venture support organization with clinical/research ties.
- Bayer Co.Lab / Pharma Accelerator: Bayer-operated pharmaceutical accelerator (formerly Grants4Apps) supporting early-stage healthtech and digital health companies; comparable to CO-AX as a corporate-sponsored healthtech accelerator offering tailored mentorship and access to industry partners.
- Nordic Health Lab: Danish healthtech hub that runs accelerator and testbed programs for Nordic startups; directly comparable to CO-AX in target customer (early-stage healthtech founders), Nordic geography, and emphasis on clinical validation and market access.
- Medicon Village Innovation Center: Swedish life science innovation park in Lund that hosts and supports biotech, medtech, and healthtech startups with lab and office facilities; comparable to CO-AX as a Swedish life science hub accelerating early-stage health ventures.
Others
- HealthTech Nordic Community: Non-profit Nordic community of 260+ healthtech, medtech, and biotech startups co-founded by CO-AX; included as an adjacent ecosystem organization whose members directly overlap with CO-AX's portfolio and value proposition.
Regional players
- Innovate UK Health & Life Sciences Catapults: UK government-backed innovation programs and Catapult network supporting healthtech startups with funding, mentorship, and testbeds; comparable to CO-AX as a publicly-backed healthtech acceleration entity but operating in the UK rather than Sweden.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
CO-AX Accelerator at Sahlgrenska Science Park social profiles
Digital presenceCO-AX Accelerator at Sahlgrenska Science Park financial estimates
Financial estimateRevenue estimate
Valuation estimate
CO-AX Accelerator at Sahlgrenska Science Park leadership team
Management profileNumber of profiles
Profiles9 records
CO-AX Accelerator at Sahlgrenska Science Park funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CO-AX Accelerator at Sahlgrenska Science Park M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CO-AX Accelerator at Sahlgrenska Science Park
What does CO-AX Accelerator at Sahlgrenska Science Park do?
CO-AX Accelerator is a healthtech-focused startup accelerator that runs tiered programs (Open Coaching, Prepare pre-incubation, Incubate, and Accelerate) and a partnership program with UC Berkeley for US Product-Market Fit assessment. It sells structured business advisory services covering capital and investments, strategy and industry insight, compliance and regulatory framework, IP and legal, funding and grants, technology and interoperability, test and validation, market access, sustainability, internationalisation, and marketing/communication. The accelerator charges a 1,000 SEK monthly fee (billed quarterly) and explicitly does not take equity in portfolio companies.
Is CO-AX Accelerator at Sahlgrenska Science Park a public or private company?
CO-AX Accelerator at Sahlgrenska Science Park is a private company. It is classified as corporate owned and is currently operating.
When was CO-AX Accelerator at Sahlgrenska Science Park founded?
CO-AX Accelerator at Sahlgrenska Science Park was founded in 2017. It employs 1 to 10 people.
Where is CO-AX Accelerator at Sahlgrenska Science Park based?
CO-AX Accelerator at Sahlgrenska Science Park is headquartered in Gothenburg, Sweden, in the Europe region.
How does CO-AX Accelerator at Sahlgrenska Science Park make money?
Two revenue lines are on record. Program Membership Fees are the primary driver. The others are soft Funding Facilitation.
Who are CO-AX Accelerator at Sahlgrenska Science Park's main competitors?
Broad incumbents on record are JLABS (Johnson & Johnson Innovation), EIT Health and Roche Pharma Day / pRED Innovation Hub. Direct peers are AstraZeneca BioVentureHub, Karolinska Institutet Innovations (KI Innovations), Bayer Co.Lab / Pharma Accelerator, Nordic Health Lab and Medicon Village Innovation Center. HealthTech Nordic Community is listed as an others. Innovate UK Health & Life Sciences Catapults is listed as a regional player.
Does CO-AX Accelerator at Sahlgrenska Science Park have an API?
No public API is recorded for CO-AX Accelerator at Sahlgrenska Science Park.
What industry is CO-AX Accelerator at Sahlgrenska Science Park in?
CO-AX Accelerator at Sahlgrenska Science Park's product category is Healthtech Startup Acceleration Services. Its primary akta.pro industry code is FSANAHAD, Corporate Accelerators & Startup Programs. Its NAICS code is 54169.